D. Boral Capital Initiates Coverage on Co-Diagnostics (NASDAQ:CODX)
Equities research analysts at D. Boral Capital started coverage on shares of Co-Diagnostics (NASDAQ:CODX – Get Free Report) in a research note issued to investors on Monday,Benzinga reports. The brokerage set a “buy” rating and a $10.00 price target on the stock. Separately, HC Wainwright cut their price target on Co-Diagnostics from $1.50 to $1.00 […]
